They pared their gains and were last up 2%. The Maryland-based biotech announced the clinical hold last month after a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback